DARE ▲ +1.4% - Daré Bioscience, Inc. $DARE - Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth Daré Bioscience's stock rose 1.4% following the company's announcement of a new NIH funding award of approximately $908,000 to support development of DARE-PTB2, a candidate therapy for preterm birth prevention. The grant reduces the company's development costs for this program and validates the clinical approach through external funding, which typically provides a modest positive signal to investors about the program's progress and feasibility. 31-AUG-2026 08:44 AM ET